0000920465-15-000019.txt : 20150408 0000920465-15-000019.hdr.sgml : 20150408 20150408192458 ACCESSION NUMBER: 0000920465-15-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150406 FILED AS OF DATE: 20150408 DATE AS OF CHANGE: 20150408 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULROY DENNIS CENTRAL INDEX KEY: 0001276840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 15760114 4 1 wf-form4_142853548890308.xml FORM 4 X0306 4 2015-04-06 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001276840 MULROY DENNIS C/O LA JOLLA PHARMACEUTICAL COMPANY, 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 18.23 2015-04-06 4 A 0 60000 0 A 2025-04-06 Common Stock 60000.0 60000 D This option represents the right to purchase up to a total of 60,000 shares of the Issuer's common stock, par value $0.0001 per share (the "Option"). The Option will vest and become exercisable with respect to 25% of the underlying shares on the first anniversary of the date of grant, and then with respect to the remaining shares, on a monthly basis over the next three years, subject to the recipient's continued service during that time. /s/ Dennis M Mulroy 2015-04-06